By: Camille Luke RDH, MSDH
March 16, 2018
In 2013, this patient was diagnosed with esophageal cancer and received surgical treatment. A comprehensive oral cancer risk assessment is necessary and recommended for everyone in our practice. OraRisk® HPV completes the comprehensive risk assessment and is especially crucial for this patient with an oral cancer history.
This case was a great learning experience on collaborating with medical providers. The thoracic surgeon was intrigued that a dental office was performing this type of screening and oral cancer risk assessment. They were quick to contact the patient and schedule a follow up visit. They were supportive of our proposed 6-month retest interval due to her history.